Mednet Logo
HomeGynecologic Oncology
Gynecologic Oncology

Gynecologic Oncology

Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.

Recent Discussions

Would you add a brachytheray boost to a locally advanced cervical cancer after surgical resection and pelvic RT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Radiation Oncology And Cyberknife Treatment Ctr

In general, a brachytherapy boost following external radiation is not standard when treating women for locally advanced cervical cancer post hysterectomy. Neither of the 2 major adjuvant GOG trials (92 and 109) allowed a brachytherapy boost, and even the currently open GOG trial, GOG 263, does not i...

Would you recommend surgery or stereotactic radiation therapy for a young woman with high-grade serous ovarian cancer presenting with a pelvic LN oligometastasis following maintenance therapy?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Like OM, the principle for other cancer favors SBRT as has excellent local control and low morbidity Donovan et al., PMID 38869888

Do you recommend Hyaluronic Acid Therapy for vaginal dryness in female patients post pelvic RT?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Maimonides Medical Center

I do not. Not saying you shouldn’t though. I recommend coconut oil which can be used with a vaginal dilator, for intercourse or purely for hydration. If ineffective, I will refer back to gynecology. There may be a role for topical estrogen depending on the cancer histology.

What is the optimal adjuvant vaginal brachytherapy schedule when a patient is getting concurrent chemotherapy?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network

I treat in the two weeks between cycles once adequately healed from surgery. Often this is between cycles 1-2 but occasionally between 2-3. I don’t modify my prescription.

How would you approach treatment for a primary carcinosarcoma of the cervix with pelvic and para-aortic nodal involvement?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

There is limited information on this situation. A series from Washington University (Gynecol Oncol 2005; 99: 348) demonstrates that curative intent treatment can be rewarded with long term survivals if disease is confined to the pelvis. Curative treatment could include chemo-RT, radical surgery, or ...

How would you approach a young patient with a locally advanced endometrial cancer with cervical involvement and a solitary bone metastasis?

2 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · University of Oklahoma Health Sciences Center

I would need to know what is meant by locally advanced endometrial cancer. Locally advanced cervical cancer usually means not operable (except IB2) so is this a T3N?M1 pt with a bone met? That is IVb. I agree with bone biopsy but endo does go to bone so I would not be surprised if this was positive....

Would you offer adjuvant RT to a FIGO IV endometrial CA with pulm mets s/p hysterectomy with residual disease, then cCR to both sites after chemotherapy?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

For stage IVB with extra pelvic mets to lung or liver, I have not offered adjuvant RT as the high risk of other mets would negate any benefit of adjuvant RT. If they develop isolated local relapse, then would consider for salvage.

How do you address extended break from EBRT during cervical cancer treatment?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

EMBRACE data suggest HRCTV dose needs to be increased by 5 Gy for each week delay beyond 50 days to counter the downside of delay. We try to do that using hybrid applicator but total dose is still limited by OAR dose and we try to push as much as we can. (HRCTV to 90-95 Gy)

Do you offer patients with advanced endometrial cancer lower starting doses of lenvatinib when used in combination with pembrolizumab given high adverse event rates with 20 mg daily?

4
3 Answers

Mednet Member
Mednet Member
Medical Oncology · Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty

For the first part of the question, "Do you offer patients with advanced endometrial cancer lower starting doses of lenvatinib when used in combination with pembrolizumab given high adverse event rates with 20 mg daily?" The strategy of administering lenvatinib therapy by starting at the established...

Is there a difference in the incidence of serious immune-related adverse events with the lenvatinib + pembrolizumab combination vs pembrolizumab alone in endometrial cancer?

1
3 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center

Yes, high risk of both hypertension and diarrhea. The diarrhea can be very difficult to manage. The lenvatinib definitely adds a level of complexity to the management of pembro side effects. This requires dose reductions and interruptions, maybe even hospitalization for dehydration/renal insufficien...